211 related articles for article (PubMed ID: 36703617)
21. The Poly(ADP-ribose) Polymerase Enzyme Tankyrase Antagonizes Activity of the β-Catenin Destruction Complex through ADP-ribosylation of Axin and APC2.
Croy HE; Fuller CN; Giannotti J; Robinson P; Foley AVA; Yamulla RJ; Cosgriff S; Greaves BD; von Kleeck RA; An HH; Powers CM; Tran JK; Tocker AM; Jacob KD; Davis BK; Roberts DM
J Biol Chem; 2016 Jun; 291(24):12747-12760. PubMed ID: 27068743
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-152-mediated dysregulation of hepatic transferrin receptor 1 in liver carcinogenesis.
Kindrat I; Tryndyak V; de Conti A; Shpyleva S; Mudalige TK; Kobets T; Erstenyuk AM; Beland FA; Pogribny IP
Oncotarget; 2016 Jan; 7(2):1276-87. PubMed ID: 26657500
[TBL] [Abstract][Full Text] [Related]
23. Calcium, calcium-sensing receptor and colon cancer.
Whitfield JF
Cancer Lett; 2009 Mar; 275(1):9-16. PubMed ID: 18725175
[TBL] [Abstract][Full Text] [Related]
24. Manipulation of iron transporter genes results in the suppression of human and mouse mammary adenocarcinomas.
Jiang XP; Elliott RL; Head JF
Anticancer Res; 2010 Mar; 30(3):759-65. PubMed ID: 20392994
[TBL] [Abstract][Full Text] [Related]
25. Haploinsufficiency of Casitas B-Lineage Lymphoma Augments the Progression of Colon Cancer in the Background of Adenomatous Polyposis Coli Inactivation.
Richards S; Walker J; Nakanishi M; Belghasem M; Lyle C; Arinze N; Napoleon MA; Ravid JD; Crossland N; Zhao Q; Rosenberg D; Rahimi N; Chitalia VC
Am J Pathol; 2020 Mar; 190(3):602-613. PubMed ID: 32113662
[TBL] [Abstract][Full Text] [Related]
26. A hypermorphic epithelial β-catenin mutation facilitates intestinal tumorigenesis in mice in response to compounding WNT-pathway mutations.
Buchert M; Rohde F; Eissmann M; Tebbutt N; Williams B; Tan CW; Owen A; Hirokawa Y; Gnann A; Orend G; Orner G; Dashwood RH; Heath JK; Ernst M; Janssen KP
Dis Model Mech; 2015 Nov; 8(11):1361-73. PubMed ID: 26398937
[TBL] [Abstract][Full Text] [Related]
27. Gut-enriched Krüppel-like factor regulates colonic cell growth through APC/beta-catenin pathway.
Stone CD; Chen ZY; Tseng CC
FEBS Lett; 2002 Oct; 530(1-3):147-52. PubMed ID: 12387883
[TBL] [Abstract][Full Text] [Related]
28. Beta-catenin/Tcf-4 inhibition after progastrin targeting reduces growth and drives differentiation of intestinal tumors.
Pannequin J; Delaunay N; Buchert M; Surrel F; Bourgaux JF; Ryan J; Boireau S; Coelho J; Pélegrin A; Singh P; Shulkes A; Yim M; Baldwin GS; Pignodel C; Lambeau G; Jay P; Joubert D; Hollande F
Gastroenterology; 2007 Nov; 133(5):1554-68. PubMed ID: 17920061
[TBL] [Abstract][Full Text] [Related]
29. Interaction of tankyrase and peroxiredoxin II is indispensable for the survival of colorectal cancer cells.
Kang DH; Lee DJ; Lee S; Lee SY; Jun Y; Kim Y; Kim Y; Lee JS; Lee DK; Lee S; Jho EH; Yu DY; Kang SW
Nat Commun; 2017 Jun; 8(1):40. PubMed ID: 28659575
[TBL] [Abstract][Full Text] [Related]
30. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
Ma L; Wang X; Jia T; Wei W; Chua MS; So S
Oncotarget; 2015 Sep; 6(28):25390-401. PubMed ID: 26246473
[TBL] [Abstract][Full Text] [Related]
31. A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth.
Lau T; Chan E; Callow M; Waaler J; Boggs J; Blake RA; Magnuson S; Sambrone A; Schutten M; Firestein R; Machon O; Korinek V; Choo E; Diaz D; Merchant M; Polakis P; Holsworth DD; Krauss S; Costa M
Cancer Res; 2013 May; 73(10):3132-44. PubMed ID: 23539443
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells.
Tan C; Costello P; Sanghera J; Dominguez D; Baulida J; de Herreros AG; Dedhar S
Oncogene; 2001 Jan; 20(1):133-40. PubMed ID: 11244511
[TBL] [Abstract][Full Text] [Related]
33. Endothelial transferrin receptor 1 contributes to thrombogenesis through cascade ferroptosis.
Ma H; Huang Y; Tian W; Liu J; Yan X; Ma L; Lai J
Redox Biol; 2024 Apr; 70():103041. PubMed ID: 38241836
[TBL] [Abstract][Full Text] [Related]
34. Olfactomedin 4 deletion induces colon adenocarcinoma in Apc
Liu W; Li H; Hong SH; Piszczek GP; Chen W; Rodgers GP
Oncogene; 2016 Oct; 35(40):5237-5247. PubMed ID: 26973250
[TBL] [Abstract][Full Text] [Related]
35. Grab regulates transferrin receptor recycling and iron uptake in developing erythroblasts.
Chen M; Zhang Y; Jiang K; Wang W; Feng H; Zhen R; Moo C; Zhang Z; Shi J; Chen C
Blood; 2022 Sep; 140(10):1145-1155. PubMed ID: 35820059
[TBL] [Abstract][Full Text] [Related]
36. Supplementation with phytoestrogens and insoluble fibers reduces intestinal carcinogenesis and restores ER-β expression in Apc-driven colorectal carcinogenesis.
Luceri C; Femia AP; Tortora K; D'Ambrosio M; Fabbri S; Fazi M; Caderni G
Eur J Cancer Prev; 2020 Jan; 29(1):27-35. PubMed ID: 31651566
[TBL] [Abstract][Full Text] [Related]
37. Partial inhibition of gp130-Jak-Stat3 signaling prevents Wnt-β-catenin-mediated intestinal tumor growth and regeneration.
Phesse TJ; Buchert M; Stuart E; Flanagan DJ; Faux M; Afshar-Sterle S; Walker F; Zhang HH; Nowell CJ; Jorissen R; Tan CW; Hirokawa Y; Eissmann MF; Poh AR; Malaterre J; Pearson HB; Kirsch DG; Provero P; Poli V; Ramsay RG; Sieber O; Burgess AW; Huszar D; Vincan E; Ernst M
Sci Signal; 2014 Sep; 7(345):ra92. PubMed ID: 25270258
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of AXIN1 and AXIN2 as targets of tankyrase inhibition in hepatocellular carcinoma cell lines.
Wang W; Liu P; Lavrijsen M; Li S; Zhang R; Li S; van de Geer WS; van de Werken HJG; Peppelenbosch MP; Smits R
Sci Rep; 2021 Apr; 11(1):7470. PubMed ID: 33811251
[TBL] [Abstract][Full Text] [Related]
39. Dietary iron enhances colonic inflammation and IL-6/IL-11-Stat3 signaling promoting colonic tumor development in mice.
Chua AC; Klopcic BR; Ho DS; Fu SK; Forrest CH; Croft KD; Olynyk JK; Lawrance IC; Trinder D
PLoS One; 2013; 8(11):e78850. PubMed ID: 24223168
[TBL] [Abstract][Full Text] [Related]
40. Adenomatous polyposis coli genotype-dependent toll-like receptor 4 activity in colon cancer.
Wen F; Liu Y; Wang W; Li M; Guo F; Sang Y; Qin Q; Wang Y; Li Q
Oncotarget; 2016 Feb; 7(7):7761-72. PubMed ID: 26760960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
